To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
PE firms eye Shanghai Pharma
One of China’s largest pharmaceutical groups is attracting interest from private equity firms after reportedly announcing that it wants to sell a large stake to foreign buyers.
